title: Activation of PTHrP gene expression in squamous carcinoma cell lines by mutant isoforms of the tumor suppressor p53.
abstract: We have evaluated the status of p53 expression in three squamous carcinoma cell lines that express high levels of PTHrP mRNA and protein and also cause hypercalcemia when grown in nude mice. All three of these lines possess a single p53 allele, each of which harbors a missense point mutation that gives rise to it mutant p53 protein with a denatured conformation. Using site-directed mutagenesis, we created a p53 expression construct bearing a missense mutation at codon 158, identical to that expressed by one of the cell lines. This construct and p53 constructs expressing representative denatured conformation mutants were then used to develop stably transfected lines, which expressed increased levels of PTHrP mRNA. Promoter-specific RNase protection indicated that this increase was due primarily to transcripts originating from the two TATA promoters, and not the GC-rich initiator element within the PTHrP gene. Cotransfection of mutant p53 expression vectors with a series of reporter constructs under the control of the human PTHrP promoter region showed that mutant p53 isoforms activated constructs containing multiple promoter elements and flanking sequences, but failed to activate constructs with individual promoters in isolation. These findings suggest that the activation of PTHrP gene expression by mutant p53 isoforms displaying a denatured conformation is dependent on interactions with sequences in the PTHrP gene regulatory region beyond the basal TATA promoters.
authors.affiliation: Department of Medicine, Yale University School of Medicine, New Haven, CT 06520, USA. jgfoley@indiana.edu
authors.forename: J
authors.initials: J
authors.lastname: Foley
authors.forename: C S
authors.initials: CS
authors.lastname: King
authors.forename: J A
authors.initials: JA
authors.lastname: Jiménez
authors.forename: J J
authors.initials: JJ
authors.lastname: Wysolmerski
authors.forename: W M
authors.initials: WM
authors.lastname: Philbrick
mesh_terms: D000483:Alleles; D000818:Animals; D015153:Blotting, Western; D002294:Carcinoma, Squamous Cell / Q000235:genetics* / Q000378:metabolism; D003062:Codon; D015972:Gene Expression Regulation, Neoplastic; D016158:Genes, p53 / Q000235:genetics*; D006801:Humans; D051379:Mice; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D020125:Mutation, Missense; D044162:Parathyroid Hormone-Related Protein; D010957:Plasmids / Q000378:metabolism; D017354:Point Mutation; D011233:Precipitin Tests; D011401:Promoter Regions, Genetic; D011487:Protein Conformation; D011489:Protein Denaturation; D020033:Protein Isoforms; D011506:Proteins / Q000235:genetics* / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D014162:Transfection; D014407:Tumor Cells, Cultured; D016159:Tumor Suppressor Protein p53 / Q000737:chemistry*
chemical_list: D003062:Codon; C470121:PTHLH protein, human; D044162:Parathyroid Hormone-Related Protein; D020033:Protein Isoforms; D011506:Proteins; D012333:RNA, Messenger; D016159:Tumor Suppressor Protein p53